MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.360
+0.010
+0.74%
After Hours: 1.350 -0.01 -0.74% 19:56 09/04 EDT
OPEN
1.320
PREV CLOSE
1.350
HIGH
1.380
LOW
1.310
VOLUME
3.57M
TURNOVER
--
52 WEEK HIGH
2.725
52 WEEK LOW
1.000
MARKET CAP
461.19M
P/E (TTM)
-5.3396
1D
5D
1M
3M
1Y
5Y
1D
Ocugen doses first patient in OCU410 trial
TipRanks · 4d ago
Ocugen Announces First Patient Dosed In Global Phase 3 Registrational Trial Of OCU410, Modifier Gene Therapy Candidate For GA Secondary To Dry Age-Related Macular Degeneration
Benzinga · 4d ago
Weekly Report: what happened at OCGN last week (0824-0828)?
Weekly Report · 5d ago
Ocugen to Participate in Upcoming September Investor and Industry Conferences
Barchart · 08/25 06:02
Weekly Report: what happened at OCGN last week (0817-0821)?
Weekly Report · 08/24 09:36
Ocugen’s Earnings Call Highlights Risk-Reward Inflection
TipRanks · 08/21 00:19
Ocugen Inc. Stock Rises 10.4%, Outperforms Market
Dow Jones · 08/19 20:33
Ocugen’s Phase 3 Gene Therapy Trial Targets High-Value Dry AMD Market
TipRanks · 08/19 16:31
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.